Gross Margin
11.86%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 2.18%.Updated Oct 25, 2026Profit Margin
-14.59%vs Specialty Chemicals peers Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -31.66%.Updated Oct 25, 2026Operating Margin
-13.16%vs Specialty Chemicals peers Updated Oct 25, 2026Return on Assets (TTM)
-3.41%vs Specialty Chemicals peers Updated Oct 25, 2026Return on Equity (TTM)
-22.35%vs Specialty Chemicals peers Updated Oct 25, 2026Revenue (TTM)
969.54MUSD1.07B · vs all stocks (USD) Updated Oct 25, 2026Revenue per Share (TTM)
4.98USDUpdated Oct 25, 2026Quarterly Revenue Growth
13.50%vs Specialty Chemicals peers Updated Oct 25, 2026Gross Profit (TTM)
21.16MUSD23.26M · vs all stocks (USD) Updated Oct 25, 2026EBITDA (TTM)
-52.00MUSD-57.17M · vs all stocks (USD) Updated Oct 25, 2026Net Income (TTM)
-306.93MUSD-337.45M · vs all stocks (USD) Updated Oct 25, 2026Quarterly Earnings Growth (YoY)
-99.70%vs Specialty Chemicals peers Updated Oct 25, 2026Operating Cash Flow (TTM)
2.32MUSD2.55M · vs all stocks (USD) Updated Oct 25, 2026Levered Free Cash Flow (TTM)
-1.77BUSD-1.94B · vs all stocks (USD) Updated Oct 25, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Oct 25, 2026Minority Interest (Equity)
300.00KUSDFY2025 · Dec 31, 2025Revenue
1.09BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.06BUSDFY2025 · Dec 31, 2025Gross Profit
23.70MUSDFY2025 · Dec 31, 2025Operating Income
-148.10MUSDFY2025 · Dec 31, 2025Pre-tax Income
-356.60MUSDFY2025 · Dec 31, 2025Income Tax Expense
-12.90MUSDFY2025 · Dec 31, 2025Net Income
183.80MUSDFY2025 · Dec 31, 2025EBIT
-309.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-147.10MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
171.70MUSDFY2025 · Dec 31, 2025Other Operating Expenses
100.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Income
54.70MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
47.60MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-343.70MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-100.00KUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
-334.20MUSDFY2025 · Dec 31, 2025Free Cash Flow
-454.40MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
17.30MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-343.70MUSDFY2025 · Dec 31, 2025Stock-based Compensation
2.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
65.40MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-125.70MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
67.80MUSDFY2025 · Dec 31, 2025Capital Expenditures
-120.20MUSDFY2025 · Dec 31, 2025Net Acquisitions
-584.20MUSDFY2025 · Dec 31, 2025Sale of Investments
1.29BUSDFY2025 · Dec 31, 2025Other Investing Activity
-84.30MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
497.30MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
98.20MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-776.70MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-1.00MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-1.67BUSDFY2025 · Dec 31, 2025Other Financing Charges
-31.10MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.38BUSDFY2025 · Dec 31, 2025